GAMMAGARD S/D IMMUNE GLOBULIN I.V. 2.5 G

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

IMMUNOGLOBULIN NORMAL HUMAN 50 MG/ML

Available from:

TEVA MEDICAL MARKETING LTD.

ATC code:

J06BA02

Pharmaceutical form:

POWDER FOR SOLUTION FOR INJECTION

Administration route:

I.V

Manufactured by:

BAXTER HEALTHCARE CORPORATION, USA

Therapeutic group:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Therapeutic indications:

Replacement therapy in:• primary immunodeficiency syndromes (PID) such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia; - common variable immunodeficiency; - severe combined immunodeficiency; - Wiskott Aldrich syndrome.• myeloma or chronic lymphocytic leukaemia (CLL) with severe secondary hypogammaglobulinaemia and recurrent infections.• children with congenital AIDS and recurrent infections.Immunomodulation• idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.• Guillain Barr? syndrome. In this case GAMMAGARD S/D (Solvent/Detergent) is only indicated in patients showing one of the following symptoms: - progressive paresis (the patient cannot walk more than 10 m on his own); - signs of a respiratory disorder (clinically observed or demonstrated by measuring the vital capacity at the patient’s bed); - signs of oropharyngeal paresis.• Kawasaki disease.Allogeneic bone marrow transplantation

Authorization date:

2010-07-01